Last reviewed · How we verify
PRGF in candidates for sperm donors
PRGF in candidates for sperm donors is a Biologic drug developed by IVI Bilbao. It is currently in Phase 2 development.
At a glance
| Generic name | PRGF in candidates for sperm donors |
|---|---|
| Sponsor | IVI Bilbao |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRGF in candidates for sperm donors CI brief — competitive landscape report
- PRGF in candidates for sperm donors updates RSS · CI watch RSS
- IVI Bilbao portfolio CI
Frequently asked questions about PRGF in candidates for sperm donors
What is PRGF in candidates for sperm donors?
PRGF in candidates for sperm donors is a Biologic drug developed by IVI Bilbao.
Who makes PRGF in candidates for sperm donors?
PRGF in candidates for sperm donors is developed by IVI Bilbao (see full IVI Bilbao pipeline at /company/ivi-bilbao).
What development phase is PRGF in candidates for sperm donors in?
PRGF in candidates for sperm donors is in Phase 2.